From: A new framework for evaluating the health impacts of treatment for Gaucher disease type 1
Starting Health State | ||||||
---|---|---|---|---|---|---|
Intact Spleen | No Spleen | |||||
Mild | Moderate | Marked with SSC | Mild | Moderate | Marked with SSC | |
Discounted QALYs | 15.73 | 15.69 | 14.92 | 15.70 | 15.65 | 14.89 |
Undiscounted QALYs | 31.16 | 31.20 | 29.73 | 31.13 | 31.16 | 29.71 |
% of Remaining Lifetime Spent in: | ||||||
Mild | 69.72 | 70.61 | 33.86 | 68.94 | 69.57 | 19.55 |
Mild with BP | 12.86 | 12.26 | 16.13 | 13.15 | 12.23 | 13.37 |
Mild with SSC | 0.73 | 0.69 | 1.17 | 0.75 | 0.70 | 1.07 |
Moderate | 15.69 | 15.58 | 42.20 | 16.14 | 16.50 | 52.97 |
Moderate with SSC | 0.53 | 0.46 | 2.76 | 0.55 | 0.54 | 5.40 |
Marked | 0.24 | 0.21 | 1.36 | 0.25 | 0.24 | 3.01 |
Marked with SSC | 0.20 | 0.17 | 2.38 | 0.21 | 0.20 | 3.02 |
Severe | 0.01 | 0.00 | 0.03 | 0.01 | 0.01 | 1.28 |
Severe with SSC | 0.02 | 0.02 | 0.12 | 0.02 | 0.02 | 0.33 |